All data are based on the daily closing price as of September 1, 2025
e
Eiken Chemical
4549.TSE
16.64 USD
0.06
+0.36%
Overview
Last close
16.64 usd
Market cap
548.75M usd
52 week high
17.03 usd
52 week low
12.38 usd
Target price
14.28 usd
Valuation
P/E
37.8769
Forward P/E
N/A
Price/Sales
1.9495
Price/Book Value
1.9244
Enterprise Value
544.19M usd
EV/Revenue
1.9737
EV/EBITDA
14.3855
Key financials
Revenue TTM
280.33M usd
Gross Profit TTM
113.32M usd
EBITDA TTM
37.36M usd
Earnings per Share
0.44 usd
Dividend
0.36 usd
Total assets
412.91M usd
Net debt
-11.58M usd
About
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.